Home » Topics » BioWorld Science

BioWorld Science
RSS

GS-0976 demonstrates significant hepatic effects in patients with NASH cirrhosis

June 5, 2018

Bayer Animal Health discovers anthelmintic compounds

June 5, 2018

Mouse models of high-grade bladder cancer for in vivo evaluation of immunotherapy presented

June 5, 2018

EMA committee backs approval of trastuzumab biosimilar Trazimera

June 4, 2018

EMA committee recommends approval of Translarna for younger children with DMD

June 4, 2018

First phase I data presented for LOXO-292 in RET-altered cancers

June 4, 2018

Novartis completes divestment of joint venture to GSK

June 4, 2018

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

Taiwan Liposome submits IND for phase I/II trial of TLC-178 in pediatric rhabdomyosarcoma

June 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026